These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4568145)

  • 1. Antibiotic sensitivity of Escherichia coli.
    Williams RF
    Br Med J; 1973 Feb; 1(5848):297. PubMed ID: 4568145
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance of urinary isolates in the community and its relation to antibiotic use.
    Raz R; Hefter H; Oren B; Kennes Y; Potasman I
    Isr J Med Sci; 1993 Apr; 29(4):207-10. PubMed ID: 8491570
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobials commonly used for urinary tract infection: sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin, nalidixic acid.
    Keys TF
    Mayo Clin Proc; 1977 Nov; 52(11):680-2. PubMed ID: 926843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferable drug resistance in Neisseria gonorrhoeae.
    Mittal V; Bhujwala RA; Shriniwas ; Pandhi RK
    Indian J Med Res; 1986 Sep; 84():252-4. PubMed ID: 3102361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effects of the combination of nitrofurantoin and trimethoprim against sensitive and nitrofurantoin and trimethoprim-resistant Escherichia coli K12.
    Obaseiki-Ebor EE
    Chemotherapy; 1985; 31(2):124-9. PubMed ID: 3886319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity to sulfamethoxazole-trimethoprim of Escherichia coli isolated from claves (author's transl)].
    Wierup M
    Nord Vet Med; 1974 Nov; 26(11):626-33. PubMed ID: 4615298
    [No Abstract]   [Full Text] [Related]  

  • 9. In-vitro sensitivity of 368 urinary organisms to trimethoprim-sulphamethoxazole and other antibacterials.
    Hunter IJ
    Med J Aust; 1970 Aug; 2(7):317-21. PubMed ID: 4319442
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rapid method for microbial resistance testing in urinary tract infections?].
    Hotz R; Binswanger U
    Schweiz Med Wochenschr; 1972 Nov; 102(45):1656-9. PubMed ID: 4486570
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cotrimoxazole resistance of Escherichia coli].
    Digranes A; Madsen ST
    Tidsskr Nor Laegeforen; 1979 Feb; 99(3):168, 156. PubMed ID: 369032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
    Madsen ST
    Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sensitivity tests in various potentially pathogenic microorganisms].
    Jedicková Z; Aldová E
    Z Gesamte Inn Med; 1972 Jan; 27(1):41. PubMed ID: 4335602
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial multi-resistence and therapeutic possibilities based on laboratory results].
    Legler F
    Arch Hyg Bakteriol; 1971 Apr; 154(5):517-23. PubMed ID: 4325417
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance of urinary tract isolates of Escherichia coli to trimethoprim, cotrimoxazole and ampicillin.
    Bailey RR; Peddie BA
    N Z Med J; 1988 Apr; 101(844):216-7. PubMed ID: 3283613
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].
    Schmid E; Price P; Krech U
    Arzneimittelforschung; 1974 Sep; 24(9):1256-8. PubMed ID: 4373015
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacterial resistance to trimethoprim-sulfamethoxazole.
    N Engl J Med; 1982 Jul; 307(1):60-2. PubMed ID: 7043275
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interaction between nalidixic acid and some antibacterial substances].
    Dominici A; Perini C
    Antibiotica; 1967 Sep; 5(3):212-23. PubMed ID: 4890810
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.